Hoche Partners Pharma Holding S.A. - 16 Apr 2025 SCHEDULE 13D/A Report for Procaps Group, S.A. Ordinary Shares, nominal value of $0.01 per share (PROCF)

Filing Manager
Hoche Partners Pharma Holding S.A.
Reporting Manager
Hoche Partners Pharma Holding S.A.
Security
Procaps Group, S.A. Ordinary Shares, nominal value of $0.01 per share
Symbol
PROCF
Shares outstanding
2,462,134,917 shares
Disclosed Ownership
2,077,549,443 shares
Ownership
84%
Form type
SCHEDULE 13D/A
Filing time
16 Apr 2025, 20:31:44 UTC
Date of event
16 Apr 2025
SEC
View on sec.gov

Quoteable Key Fact

"Hoche Partners Pharma Holding S.A. disclosed 84% ownership in Procaps Group, S.A. Ordinary Shares, nominal value of $0.01 per share (PROCF) on 16 Apr 2025."

Quick Takeaways

  • Hoche Partners Pharma Holding S.A. filed SCHEDULE 13D/A for Procaps Group, S.A. Ordinary Shares, nominal value of $0.01 per share (PROCF).
  • Disclosed ownership: 84%.
  • Date of event: 16 Apr 2025.

What Changed

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 16 Apr 2025, 20:31.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Source Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (1)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Hoche Partners Pharma Holding S.A. 84% 2,077,549,443 773,031,209 1,304,518,234 /s/ Roman Sokolowski Roman Sokolowski/Director 0001884588